193 related articles for article (PubMed ID: 38018436)
1. Flipped C-Terminal Ends of APOA1 Promote ABCA1-Dependent Cholesterol Efflux by Small HDLs.
He Y; Pavanello C; Hutchins PM; Tang C; Pourmousa M; Vaisar T; Song HD; Pastor RW; Remaley AT; Goldberg IJ; Costacou T; Sean Davidson W; Bornfeldt KE; Calabresi L; Segrest JP; Heinecke JW
Circulation; 2024 Mar; 149(10):774-787. PubMed ID: 38018436
[TBL] [Abstract][Full Text] [Related]
2. Flipped C-Terminal Ends of APOA1 Promote ABCA1-dependent Cholesterol Efflux by Small HDLs.
He Y; Pavanello C; Hutchins PM; Tang C; Pourmousa M; Vaisar T; Song HD; Pastor RW; Remaley AT; Goldberg IJ; Costacou T; Davidson WS; Bornfeldt KE; Calabresi L; Segrest JP; Heinecke JW
medRxiv; 2023 Nov; ():. PubMed ID: 37961344
[TBL] [Abstract][Full Text] [Related]
3. Diabetes Impairs Cellular Cholesterol Efflux From ABCA1 to Small HDL Particles.
He Y; Ronsein GE; Tang C; Jarvik GP; Davidson WS; Kothari V; Song HD; Segrest JP; Bornfeldt KE; Heinecke JW
Circ Res; 2020 Oct; 127(9):1198-1210. PubMed ID: 32819213
[TBL] [Abstract][Full Text] [Related]
4. HDL particle size is a critical determinant of ABCA1-mediated macrophage cellular cholesterol export.
Du XM; Kim MJ; Hou L; Le Goff W; Chapman MJ; Van Eck M; Curtiss LK; Burnett JR; Cartland SP; Quinn CM; Kockx M; Kontush A; Rye KA; Kritharides L; Jessup W
Circ Res; 2015 Mar; 116(7):1133-42. PubMed ID: 25589556
[TBL] [Abstract][Full Text] [Related]
5. Increased ABCA1 (ATP-Binding Cassette Transporter A1)-Specific Cholesterol Efflux Capacity in Schizophrenia.
Luquain-Costaz C; Kockx M; Anastasius M; Chow V; Kontush A; Jessup W; Kritharides L
Arterioscler Thromb Vasc Biol; 2020 Nov; 40(11):2728-2737. PubMed ID: 32907370
[TBL] [Abstract][Full Text] [Related]
6. Proteomic analysis of HDL from inbred mouse strains implicates APOE associated with HDL in reduced cholesterol efflux capacity via the ABCA1 pathway.
Pamir N; Hutchins P; Ronsein G; Vaisar T; Reardon CA; Getz GS; Lusis AJ; Heinecke JW
J Lipid Res; 2016 Feb; 57(2):246-57. PubMed ID: 26673204
[TBL] [Abstract][Full Text] [Related]
7. Conformational flexibility of apolipoprotein A-I amino- and carboxy-termini is necessary for lipid binding but not cholesterol efflux.
Bedi S; Morris J; Shah A; Hart RC; Jerome WG; Aller SG; Tang C; Vaisar T; Bornfeldt KE; Segrest JP; Heinecke JW; Davidson WS
J Lipid Res; 2022 Mar; 63(3):100168. PubMed ID: 35051413
[TBL] [Abstract][Full Text] [Related]
8. Structure-function relationships in reconstituted HDL: Focus on antioxidative activity and cholesterol efflux capacity.
Cukier AMO; Therond P; Didichenko SA; Guillas I; Chapman MJ; Wright SD; Kontush A
Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Sep; 1862(9):890-900. PubMed ID: 28529180
[TBL] [Abstract][Full Text] [Related]
9. Nascent HDL (High-Density Lipoprotein) Discs Carry Cholesterol to HDL Spheres: Effects of HDL Particle Remodeling on Cholesterol Efflux.
Navdaev AV; Sborgi L; Wright SD; Didichenko SA
Arterioscler Thromb Vasc Biol; 2020 May; 40(5):1182-1194. PubMed ID: 32131613
[TBL] [Abstract][Full Text] [Related]
10. HDL Particle Concentration and Size Predict Incident Coronary Artery Disease Events in People with Type 1 Diabetes.
Costacou T; Vaisar T; Miller RG; Davidson WS; Heinecke JW; Orchard TJ; Bornfeldt KE
medRxiv; 2023 Nov; ():. PubMed ID: 37986833
[TBL] [Abstract][Full Text] [Related]
11. Cell lipid metabolism modulators 2-bromopalmitate, D609, monensin, U18666A and probucol shift discoidal HDL formation to the smaller-sized particles: implications for the mechanism of HDL assembly.
Quach D; Vitali C; La FM; Xiao AX; Millar JS; Tang C; Rader DJ; Phillips MC; Lyssenko NN
Biochim Biophys Acta; 2016 Dec; 1861(12 Pt A):1968-1979. PubMed ID: 27671775
[TBL] [Abstract][Full Text] [Related]
12. Role of apoA-I, ABCA1, LCAT, and SR-BI in the biogenesis of HDL.
Zannis VI; Chroni A; Krieger M
J Mol Med (Berl); 2006 Apr; 84(4):276-94. PubMed ID: 16501936
[TBL] [Abstract][Full Text] [Related]
13. Cholesterol Efflux Capacity and Subclasses of HDL Particles in Healthy Women Transitioning Through Menopause.
El Khoudary SR; Hutchins PM; Matthews KA; Brooks MM; Orchard TJ; Ronsein GE; Heinecke JW
J Clin Endocrinol Metab; 2016 Sep; 101(9):3419-28. PubMed ID: 27399353
[TBL] [Abstract][Full Text] [Related]
14. Niacin Therapy Increases High-Density Lipoprotein Particles and Total Cholesterol Efflux Capacity But Not ABCA1-Specific Cholesterol Efflux in Statin-Treated Subjects.
Ronsein GE; Hutchins PM; Isquith D; Vaisar T; Zhao XQ; Heinecke JW
Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):404-11. PubMed ID: 26681752
[TBL] [Abstract][Full Text] [Related]
15. Plasminogen promotes cholesterol efflux by the ABCA1 pathway.
Pamir N; Hutchins PM; Ronsein GE; Wei H; Tang C; Das R; Vaisar T; Plow E; Schuster V; Koschinsky ML; Reardon CA; Weinberg R; Dichek DA; Marcovina S; Getz GS; Heinecke JW
JCI Insight; 2017 Aug; 2(15):. PubMed ID: 28768900
[TBL] [Abstract][Full Text] [Related]
16. The role of HDL- and non-HDL-related parameters in cell-cholesterol efflux capacity.
Asztalos BF; Hauser TH; Goldfine AB; Welty FK; Horvath KV; Schaefer EJ
Atherosclerosis; 2022 Mar; 345():1-6. PubMed ID: 35183903
[TBL] [Abstract][Full Text] [Related]
17. V-ATPase (Vacuolar ATPase) Activity Required for ABCA1 (ATP-Binding Cassette Protein A1)-Mediated Cholesterol Efflux.
Lorkowski SW; Brubaker G; Gulshan K; Smith JD
Arterioscler Thromb Vasc Biol; 2018 Nov; 38(11):2615-2625. PubMed ID: 30354238
[TBL] [Abstract][Full Text] [Related]
18. HDL particle size is increased and HDL-cholesterol efflux is enhanced in type 1 diabetes: a cross-sectional study.
Ahmed MO; Byrne RE; Pazderska A; Segurado R; Guo W; Gunness A; Frizelle I; Sherlock M; Ahmed KS; McGowan A; Moore K; Boran G; McGillicuddy FC; Gibney J
Diabetologia; 2021 Mar; 64(3):656-667. PubMed ID: 33169205
[TBL] [Abstract][Full Text] [Related]
19. Humans with atherosclerosis have impaired ABCA1 cholesterol efflux and enhanced high-density lipoprotein oxidation by myeloperoxidase.
Shao B; Tang C; Sinha A; Mayer PS; Davenport GD; Brot N; Oda MN; Zhao XQ; Heinecke JW
Circ Res; 2014 May; 114(11):1733-42. PubMed ID: 24647144
[TBL] [Abstract][Full Text] [Related]
20. Increased prevalence of clinical and subclinical atherosclerosis in patients with damaging mutations in ABCA1 or APOA1.
Abdel-Razek O; Sadananda SN; Li X; Cermakova L; Frohlich J; Brunham LR
J Clin Lipidol; 2018; 12(1):116-121. PubMed ID: 29150341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
